Home » Medical Devices » Radiofrequency Ablation Devices Market Size, Share, Analysis Report
The Global Radiofrequency Ablation Devices Market US$ 1,580.0 Million by the end of 2028, with the demand projected to increment at a CAGR of 12.5% during the forecast period of 2023 to 2028.
Radiofrequency ablation is a minimally invasive procedure, appropriate for patients with cardiac diseases cancer and pain management. It is become a way of choice due to its high efficacy, simple use, and safety. RFA is being increasingly used for the treatment of the many diseases. like cancer and arrhythmia.
The market development is favoured by the rise in prevalence of cardiovascular diseases, such as, fibrillation, incidence of patients affected by cancer and pain, and increase in demand for minimally-invasive procedures. The utilization of ultrasound ablation technology in RFAD is additionally augmenting the recognition of those devices. However, the market is restricted by the high treatment cost, low awareness about the procedure, and availability of other treatments. It is estimated that the impact of drivers is predicted to be above the restraints. Furthermore, lucrative growth opportunities, like expansion in emerging markets, untapped market within the developing regions, and technological advancements in RFA.
The global Radiofrequency Ablation Devices market is segregated on the basis of Application as Cardiology, Oncology, and Pain management. Based on Product Type the global Radiofrequency Ablation Devices market is segmented in Devices and Disposables.
The global Radiofrequency Ablation Devices market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Radiofrequency Ablation Devices market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Halyard Health, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic Plc, Boston Scientific Corporation, C. R. Bard, Inc., AngioDynamics, Inc., Hologic, Inc., AtriCure, Inc., Johnson & Johnson, and others are among the major players in the global Radiofrequency Ablation Devices market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Radiofrequency Ablation Devices Market has been segmented as below:
Radiofrequency Ablation Devices Market, By Application
Radiofrequency Ablation Devices Market, By Product Type
Radiofrequency Ablation Devices Market, By Region
Radiofrequency Ablation Devices Market, By Company
The report covers:
Report Scope:
The global Radiofrequency Ablation Devices market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Radiofrequency Ablation Devices market share. Major industry players with significant revenue share include Halyard Health, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic Plc, Boston Scientific Corporation, C. R. Bard, Inc., AngioDynamics, Inc., Hologic, Inc., AtriCure, Inc., Johnson & Johnson, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
OTC Braces and Supports Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Radiofrequency Ablation Devices Market, By Application
5.1 Introduction
5.2 Cardiology
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Oncology
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Pain management
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Radiofrequency Ablation Devices Market, By Product Type
6.1 Introduction
6.2 Devices
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Disposables
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Radiofrequency Ablation Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Radiofrequency Ablation Devices, By Application
7.2.2 North America Radiofrequency Ablation Devices, By Product Type
7.3 Europe
7.3.1 Europe Radiofrequency Ablation Devices, By Application
7.3.2 Europe Radiofrequency Ablation Devices, By Product Type
7.4 Asia-Pacific
7.4.1 Asia-Pacific Radiofrequency Ablation Devices, By Application
7.4.2 Asia-Pacific Radiofrequency Ablation Devices, By Product Type
7.5 Rest of the World
7.5.1 Rest of the World Radiofrequency Ablation Devices, By Application
7.5.2 Rest of the World Radiofrequency Ablation Devices, By Product Type
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
9.1 Halyard Health, Inc.
9.2 Stryker Corporation
9.3 St. Jude Medical, Inc.
9.4 Medtronic Plc
9.5 Boston Scientific Corporation
9.6 C. R. Bard, Inc.
9.7 AngioDynamics, Inc.
9.8 Hologic, Inc.
9.9 AtriCure, Inc.
9.10 Johnson & Johnson
9.11 Baylis Medical
9.12 Arthrex, Inc.
9.13 Inomed Medizintechnik GmbH
9.14 Sutter Medizintechnik GmbH
9.15 Bramsys Indústria e Comércio Ltda
9.16 ENDO-FLEX GmbH
9.17 Epimed International
9.18 Sfm medical devices GmbH
The Radiofrequency Ablation Devices Market has been segmented as below:
Radiofrequency Ablation Devices Market, By Application
Radiofrequency Ablation Devices Market, By Product Type
Radiofrequency Ablation Devices Market, By Region
Radiofrequency Ablation Devices Market, By Company